Navigation Links
FASEB SRC announces conference registration open for: Neural Mechanisms in Cardiovascular Regulation

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Neural Mechanisms in Cardiovascular Regulation.

The 2013 FASEB Science Research Conference, Neural Mechanisms in Cardiovascular Regulation, is an important and unique scientific conference that will focus on neural mechanisms that regulate normal cardiovascular function, and how dysregulation of these control systems contributes to the etiology of cardiovascular (and related) diseases such as arterial hypertension, heart failure, stroke, sleep apnea, and obesity/diabetes.

The conference brings together a diverse, world-class group of scientists interested in fundamental neuro-cardiovascular mechanisms, including integrative physiologists, neuroscientists, cell & molecular biologists, geneticists and clinical investigators. The primary objectives are to 1) create a forum for in-depth discussion of the latest research discoveries in this area, and 2) actively engage young investigators in this international, high-quality scientific meeting with neural mechanisms of cardiovascular regulation as its central theme.


Contact: Robin Crawford, CMP
Federation of American Societies for Experimental Biology

Page: 1

Related biology news :

1. FASEB SRC announces conference: Matricellular Proteins in Development, Health, and Disease
2. FASEB SRC announces conference registration open for: Biology and Chemistry of Vision
3. FASEB SRC announces conference registration open for: Hematologic Malignancies
4. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
5. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
6. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
7. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
8. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
9. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
10. FASEB urges biomedical research community to speak out against sequestration
11. FASEB lauds Air India for transporting research animals
Post Your Comments:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and ... and the 6000i models are higher end machines that use the more unconventional z-dimension ... light beam from the bottom of the cuvette holder. , FireflySci has developed ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: